Common Contracts
6 similar Form of Support Agreement contracts by Nivalis Therapeutics, Inc., Mirna Therapeutics, Inc., Synlogic, Inc.
FORM OF SUPPORT AGREEMENTForm of Support Agreement • May 23rd, 2017 • Synlogic, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of May , 2017, is by and between Synlogic, Inc., a Delaware corporation (the “Company”), and the Person set forth on Schedule A (the “Stockholder”).
FORM OF SUPPORT AGREEMENTForm of Support Agreement • May 16th, 2017 • Mirna Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of May , 2017, is by and between Mirna Therapeutics, Inc., a Delaware corporation (“Meerkat”), and the Person set forth on Schedule A (the “Stockholder”).
FORM OF SUPPORT AGREEMENTForm of Support Agreement • May 16th, 2017 • Mirna Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of May , 2017, is by and between Synlogic, Inc., a Delaware corporation (the “Company”), and the Person set forth on Schedule A (the “Stockholder”).
FORM OF SUPPORT AGREEMENTForm of Support Agreement • April 18th, 2017 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [_], 2017, is by and between Alpine Immune Sciences, Inc., a Delaware corporation (the “Company”), and the Person set forth on Schedule A (the “Stockholder”).
FORM OF SUPPORT AGREEMENTForm of Support Agreement • April 18th, 2017 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [_] , 2017, is by and between Alpine Immune Sciences, Inc., a Delaware corporation (the “Company”), and the Person set forth on Schedule A (the “Stockholder”).
FORM OF SUPPORT AGREEMENTForm of Support Agreement • April 18th, 2017 • Nivalis Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This SUPPORT AGREEMENT (this “Agreement”), dated as of [·], 2017, is by and between Alpine Immune Sciences, Inc., a Delaware corporation (the “Company”), and the Person set forth on Schedule A (the “Stockholder”).
